Panagora Asset Management Inc Gilead Sciences, Inc. Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

A detailed history of Panagora Asset Management Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 1,163,742 shares of GILD stock, worth $103 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

1,163,742

Previous 584,626 99.06%

Holding current value

$103 Million

Previous $40.1 Million 143.19%

% of portfolio

0.48%

Previous 0.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $38.6 Million - $48.6 Million	579,116 Added 99.06%	1,163,742 $97.5 Million
Q2 2024 Jul 29, 2024	BUY	$63.15 - $72.88 $30.8 Million - $35.6 Million	488,012 Added 505.12%	584,626 $40.1 Million
Q1 2024 May 07, 2024	SELL	$71.58 - $87.29 $277,086 - $337,899	-3,871 Reduced 3.85%	96,614 $7.08 Million
Q4 2023 Feb 08, 2024	SELL	$73.27 - $83.09 $64.8 Million - $73.5 Million	-884,120 Reduced 89.79%	100,485 $8.14 Million
Q3 2023 Oct 31, 2023	BUY	$73.94 - $80.67 $9.02 Million - $9.84 Million	121,980 Added 14.14%	984,605 $73.8 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $14,365 - $16,386	-189 Reduced 0.02%	862,625 $66.5 Million
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $8.37 Million - $9.53 Million	-108,212 Reduced 11.14%	862,814 $71.6 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $3.3 Million - $4.74 Million	-52,992 Reduced 5.17%	971,026 $83.4 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $11 Million - $12.5 Million	183,958 Added 21.9%	1,024,018 $63.2 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $13.8 Million - $15.5 Million	238,402 Added 39.62%	840,060 $51.9 Million
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $15.9 Million - $19.9 Million	-273,755 Reduced 31.27%	601,658 $35.8 Million
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $40.8 Million - $46.3 Million	-629,258 Reduced 41.82%	875,413 $63.6 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $27.6 Million - $29.8 Million	408,245 Added 37.23%	1,504,671 $105 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $14.2 Million - $15.5 Million	223,467 Added 25.6%	1,096,426 $75.5 Million
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $2.6 Million - $2.96 Million	43,282 Added 5.22%	872,959 $56.4 Million
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $3.7 Million - $4.21 Million	65,249 Added 8.54%	829,677 $48.3 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $6.99 Million - $8.79 Million	-112,629 Reduced 12.84%	764,428 $48.3 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $239,228 - $277,788	-3,307 Reduced 0.38%	877,057 $67.5 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $11.6 Million - $14.9 Million	185,645 Added 26.72%	880,364 $65.8 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $32.7 Million - $36 Million	531,288 Added 325.08%	694,719 $45.1 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $1.12 Million - $1.24 Million	-17,912 Reduced 9.88%	163,431 $10.4 Million
Q2 2019 Aug 09, 2019	SELL	$61.87 - $69.38 $39.1 Million - $43.8 Million	-631,694 Reduced 77.7%	181,343 $12.3 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $9.21 Million - $10.3 Million	-147,353 Reduced 15.34%	813,037 $52.9 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $16.3 Million - $21.2 Million	268,553 Added 38.82%	960,390 $60.1 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $19.1 Million - $21.1 Million	267,906 Added 63.2%	691,837 $53.4 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $6.1 Million - $7.11 Million	-93,993 Reduced 18.15%	423,931 $30 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $38.1 Million - $46.5 Million	-523,582 Reduced 50.27%	517,924 $39 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $42.8 Million - $50.2 Million	-600,970 Reduced 36.59%	1,041,506 $74.6 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $118 Million - $140 Million	1,642,476	1,642,476 $133 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Gilead Sciences, Inc. Transaction History